I den egnede patientpopulation og intent- to- treat- populationen blev der demonstreret non- inferioritet af XELOX. armen, sammenlignet med FOLFOX- 4- armen, med hensyn til progressionsfri overlevelse (se tabel 7).
Non-inferiority of the XELOX-containing arms compared with the FOLFOX-4-containing arms in the overall comparison was demonstrated in terms of progression-free survival in the eligible patient population and the intent-to-treat population (see Table 7).